Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-01-09 Regulatory Filings
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic partnership between Indegene and CliniOps to accelerate clinical trials. It is addressed to stock exchanges pursuant to SEBI regulations and includes a press release dated January 09, 2025. The content focuses on the partnership and business strategy rather than financial results, management changes, or regulatory filings. It does not contain financial statements, voting results, or legal proceedings. The document is not a report but an announcement of a corporate development. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-01-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window for insiders due to the upcoming finalization and approval of financial results for the quarter ending December 31, 2024. It references SEBI regulations and the company's code of conduct for insider trading. The document does not contain any financial data, results, or detailed report content. It is a regulatory announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1968 characters), and it serves as an intimation rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2024-12-30 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a short communication addressed to stock exchanges informing about the outcome of resolutions passed by circulation by the Board of Directors. The resolutions pertain to allotment of shares under ESOP and RSU plans. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which relates to disclosure of material events. The document is brief (1516 characters) and serves as an announcement of decisions made by the board rather than a detailed report or financial statement. It does not contain financial data or detailed analysis, nor is it a report or presentation. It is an update on capital structure changes (share allotment under employee plans). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-12-27 English
Updates
Director's Dealing Classification · 95% confidence The document is a disclosure pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. It contains detailed information about insider trading transactions by a designated person (Chairman and CEO) including shareholding before and after the transaction, dates, transaction type, and exchange details. The document is a formal regulatory disclosure of insider trading activity, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a compliance filing related to insider trading disclosures. Therefore, it fits best under the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 5798 characters, sufficient to contain substantive details of the insider transaction. Confidence is high due to clear regulatory references and detailed transaction data.
2024-12-27 English
Updates
Director's Dealing Classification · 100% confidence The document is a disclosure pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding the sale of equity shares by designated persons of the company. It is a regulatory compliance filing related to insider trading disclosures, not a financial report, management change, or other specific report types. The document is short (1567 characters) and serves as a notification of insider transactions. Therefore, it fits the category of Director's Dealing (DIRS).
2024-12-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of an investor/analyst meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and states that the company officials will meet investors/analysts to discuss publicly available documents. There is no financial data, report content, or detailed presentation included. The document is an announcement of an upcoming event rather than a report or transcript. Given the short length (1803 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories like Investor Presentation or Call Transcript, which would contain more detailed content.
2024-12-18 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.